931 related articles for article (PubMed ID: 19828625)
1. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.
Alexaki VI; Notas G; Pelekanou V; Kampa M; Valkanou M; Theodoropoulos P; Stathopoulos EN; Tsapis A; Castanas E
J Immunol; 2009 Nov; 183(9):5948-56. PubMed ID: 19828625
[TBL] [Abstract][Full Text] [Related]
2. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
[TBL] [Abstract][Full Text] [Related]
3. Identification of proteoglycans as the APRIL-specific binding partners.
Ingold K; Zumsteg A; Tardivel A; Huard B; Steiner QG; Cachero TG; Qiang F; Gorelik L; Kalled SL; Acha-Orbea H; Rennert PD; Tschopp J; Schneider P
J Exp Med; 2005 May; 201(9):1375-83. PubMed ID: 15851487
[TBL] [Abstract][Full Text] [Related]
4. BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors.
Zhang X; Park CS; Yoon SO; Li L; Hsu YM; Ambrose C; Choi YS
Int Immunol; 2005 Jun; 17(6):779-88. PubMed ID: 15908449
[TBL] [Abstract][Full Text] [Related]
5. APRIL and BAFF proteins increase proliferation of human adipose-derived stem cells through activation of Erk1/2 MAP kinase.
Zonca M; Mancheño-Corvo P; DelaRosa O; Mañes S; Büscher D; Lombardo E; Planelles L
Tissue Eng Part A; 2012 Apr; 18(7-8):852-9. PubMed ID: 22059379
[TBL] [Abstract][Full Text] [Related]
6. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
Katsenelson N; Kanswal S; Puig M; Mostowski H; Verthelyi D; Akkoyunlu M
Eur J Immunol; 2007 Jul; 37(7):1785-95. PubMed ID: 17557373
[TBL] [Abstract][Full Text] [Related]
7. BAFF, APRIL and their receptors: structure, function and signaling.
Bossen C; Schneider P
Semin Immunol; 2006 Oct; 18(5):263-75. PubMed ID: 16914324
[TBL] [Abstract][Full Text] [Related]
8. TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties.
Mackay F; Schneider P
Cytokine Growth Factor Rev; 2008; 19(3-4):263-76. PubMed ID: 18514565
[TBL] [Abstract][Full Text] [Related]
9. The uncertain glory of APRIL.
Medema JP; Planelles-Carazo L; Hardenberg G; Hahne M
Cell Death Differ; 2003 Oct; 10(10):1121-5. PubMed ID: 14502235
[TBL] [Abstract][Full Text] [Related]
10. BAFF costimulation of Toll-like receptor-activated B-1 cells.
Ng LG; Ng CH; Woehl B; Sutherland AP; Huo J; Xu S; Mackay F; Lam KP
Eur J Immunol; 2006 Jul; 36(7):1837-46. PubMed ID: 16791880
[TBL] [Abstract][Full Text] [Related]
11. Identification of new splice variants of the genes BAFF and BCMA.
Smirnova AS; Andrade-Oliveira V; Gerbase-DeLima M
Mol Immunol; 2008 Feb; 45(4):1179-83. PubMed ID: 17825416
[TBL] [Abstract][Full Text] [Related]
12. Expression of BAFF-R and TACI in reactive lymphoid tissues and B-cell lymphomas.
Wada K; Maeda K; Tajima K; Kato T; Kobata T; Yamakawa M
Histopathology; 2009 Jan; 54(2):221-32. PubMed ID: 19207947
[TBL] [Abstract][Full Text] [Related]
13. The BAFF/APRIL system: life beyond B lymphocytes.
Ng LG; Mackay CR; Mackay F
Mol Immunol; 2005 May; 42(7):763-72. PubMed ID: 15829264
[TBL] [Abstract][Full Text] [Related]
14. BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysis.
Pelekanou V; Notas G; Kampa M; Tsentelierou E; Stathopoulos EN; Tsapis A; Castanas E
PLoS One; 2013; 8(12):e83250. PubMed ID: 24376672
[TBL] [Abstract][Full Text] [Related]
15. B-cell maturation antigen (BCMA) activation exerts specific proinflammatory effects in normal human keratinocytes and is preferentially expressed in inflammatory skin pathologies.
Alexaki VI; Pelekanou V; Notas G; Venihaki M; Kampa M; Dessirier V; Sabour-Alaoui S; Stathopoulos EN; Tsapis A; Castanas E
Endocrinology; 2012 Feb; 153(2):739-49. PubMed ID: 22166983
[TBL] [Abstract][Full Text] [Related]
16. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF.
Thompson JS; Bixler SA; Qian F; Vora K; Scott ML; Cachero TG; Hession C; Schneider P; Sizing ID; Mullen C; Strauch K; Zafari M; Benjamin CD; Tschopp J; Browning JL; Ambrose C
Science; 2001 Sep; 293(5537):2108-11. PubMed ID: 11509692
[TBL] [Abstract][Full Text] [Related]
17. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL.
He B; Chadburn A; Jou E; Schattner EJ; Knowles DM; Cerutti A
J Immunol; 2004 Mar; 172(5):3268-79. PubMed ID: 14978135
[TBL] [Abstract][Full Text] [Related]
18. TACI attenuates antibody production costimulated by BAFF-R and CD40.
Sakurai D; Kanno Y; Hase H; Kojima H; Okumura K; Kobata T
Eur J Immunol; 2007 Jan; 37(1):110-8. PubMed ID: 17154264
[TBL] [Abstract][Full Text] [Related]
19. APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop.
Moreaux J; Sprynski AC; Dillon SR; Mahtouk K; Jourdan M; Ythier A; Moine P; Robert N; Jourdan E; Rossi JF; Klein B
Eur J Haematol; 2009 Aug; 83(2):119-29. PubMed ID: 19456850
[TBL] [Abstract][Full Text] [Related]
20. Age-related changes in BAFF and APRIL profiles and upregulation of BAFF and APRIL expression in patients with primary antibody deficiency.
Jin R; Kaneko H; Suzuki H; Arai T; Teramoto T; Fukao T; Kondo N
Int J Mol Med; 2008 Feb; 21(2):233-8. PubMed ID: 18204790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
